Dr. Xiangyang Xu is a PhD candidate in Cardiothoracic Surgery at the First Affiliated Hospital of Naval Medical University, specializing in valvular heart disease and cardiomyopathy. His research on postoperative management in high-risk valvular patients has been published in Shock, and he has further contributed to the field with publications in Heart, Lung and Circulation and International Journal of Biological Sciences on aortic dissection and cardiomyopathy, respectively. He has presented his work at a national cardiovascular conference in China. Dr. Xu's current research is focused on the regulatory role of cardiac autonomic nerves in disease progression, underpinned by a robust experimental research platform he has established for dilated cardiomyopathy.